Vivoryon Therapeutics VVY

AMS: VVY | ISIN: NL00150002Q7 13/03/2026

1,354 EUR (-1,88%)

(-1,88%) 13/03/2026

Grafiek Vivoryon Therapeutics AG

Grafiek Vivoryon Therapeutics AG

1 dag1d -1,88%
1 week1w -1,74%
1 maand1m -3,29%
3 maanden3m -10,33%
6 maanden6m -19,31%
1 jaar1j -28,74%
5 jaar5j -90,85%

Vivoryon Therapeutics AG in het nieuws

Toon enkel gratis nieuws

7 januari 2026 · Vivoryon Therapeutics N.V. to Attend and Present in Upcoming Conferences · Persbericht

4 december 2025 · Vivoryon Therapeutics N.V. Reports Q3 2025 Financial Results and Business Updates · Persbericht

25 november 2025 · Vivoryon Therapeutics N.V. to Report Q3 2025 Financial Results and Operational Progress on December 4, 2025 · Persbericht

6 november 2025 · Vivoryon Therapeutics N.V. Presents Phase 2 Kidney Function and Biomarker Data at the American Society of Nephrology Kidney Week 2025 · Persbericht

3 november 2025 · Vivoryon Therapeutics N.V. to Present at Upcoming Conferences · Persbericht

6 oktober 2025 · Vivoryon Therapeutics N.V. Successfully Completes Private Placement Raising EUR 5.1 Million · Persbericht

4 september 2025 · Vivoryon Therapeutics N.V. Reports H1 2025 Financial Results and Business Updates · Persbericht

27 augustus 2025 · Vivoryon Therapeutics N.V. to Report H1 2025 Financial Results and Operational Progress on September 4, 2025 · Persbericht

27 juni 2025 · Vivoryon Therapeutics N.V. to Present at Upcoming Investor Conferences · Persbericht

24 juni 2025 · Vivoryon Therapeutics N.V. Reports Outcome of 2025 Annual General Meeting · Persbericht

Profiel Vivoryon Therapeutics AG

Gezondheidstechnologie

Website: www.probiodrug.de

Hoofdzetel: Halle Duitsland

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe